TNF-based isolated limb perfusion in unresectable extremity desmoid tumours

European Journal of Surgical Oncology

Volumn 31, Issue 8, 2005, Pages 912-916

  Grunhagen D J ^a   de Wilt, J H W ^a   Verhoef, C ^a   van Geel, A N ^a   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aggressive fibromatosis; Isolated limb perfusion; Melphalan; Soft tissue sarcoma; TNF

Indexed keywords

GAMMA INTERFERON; MELPHALAN; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ADVANCED CANCER; ARM DISEASE; ARTICLE; BLISTER; CLINICAL ARTICLE; DESMOID TUMOR; DRUG DOSE REGIMEN; EDEMA; ERYTHEMA; FEMALE; HUMAN; INOPERABLE CANCER; ISOLATED LIMB PERFUSION; LEG DISEASE; LIMB PERFUSION; LIMB SALVAGE; LIMB TUMOR; MALE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; SIDE EFFECT; SOFT TISSUE SARCOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DERMOID CYST; DISEASE PROGRESSION; FEMALE; HUMANS; LIMB SALVAGE; LOWER EXTREMITY; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; REMISSION INDUCTION; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UPPER EXTREMITY;

EID: 26444621299     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.07.002     Document Type: Article

References (19)

1. A.M. Eggermont H. Schraffordt Koops J.M. Klausner B.B. Kroon P.M. Schlag D. Lienard et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience [discussion 764-5] Ann Surg 224 1996 756-764
2. A.M. Eggermont H. Schraffordt Koops D. Lienard B.B. Kroon A.N. van Geel H.J. Hoekstra et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial J Clin Oncol 14 1996 2653-2665
3. J.M. Klaase B.B. Kroon E.A. van Slooten C. Benckhuijsen Relation between calculated melphalan peak concentrations and toxicity in regional isolated limb perfusion for melanoma Reg Cancer Treat 4 1992 223-226
4. C.S. van Rijswijk M.J. Geirnaerdt P.C. Hogendoorn J.L. Peterse F. van Coevorden A.H. Taminiau et al. Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: Initial results Eur Radiol 13 2003 1849-1858
5. D. Vanel S. Bonvalot J.M. Guinebretiere P. Petrow C. Dromain H. Caillet MR imaging in the evaluation of isolated limb perfusion: A prospective study of 18 cases Skeletal Radiol 33 2004 150-156
6. J. Wieberdink C. Benckhuysen R.P. Braat E.A. van Slooten G.A. Olthuis Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions Eur J Cancer Clin Oncol 18 1982 905-910
7. D. Lev-Chelouche S. Abu-Abeid R. Nakache J. Issakov Y. Kollander O. Merimsky et al. Limb desmoid tumors: A possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan Surgery 126 1999 963-967
8. J.J. Lewis P.J. Boland D.H. Leung J.M. Woodruff M.F. Brennan The enigma of desmoid tumors Ann Surg 229 1999 866-872 [discussion 872-3]
9. M.G. Rock D.J. Pritchard H.M. Reiman E.H. Soule R.C. Brewster Extra-abdominal desmoid tumors J Bone Joint Surg Am 66 1984 1369-1374
10. A.J. Weiss R.D. Lackman Low-dose chemotherapy of desmoid tumors Cancer 64 1989 1192-1194
11. N. Wilcken M.H. Tattersall Endocrine therapy for desmoid tumors Cancer 68 1991 1384-1388
12. B.W. Goy S.P. Lee F. Eilber F. Dorey J. Eckardt Y.S. Fu et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors Int J Radiat Oncol Biol Phys 39 1997 659-665
13. M.A. Spear L.C. Jennings H.J. Mankin I. Spiro D.S. Springfield M.C. Gebhardt et al. Individualizing management of aggressive fibromatoses Int J Radiat Oncol Biol Phys 40 1998 637-645
14. M.T. Ballo G.K. Zagars A. Pollack P.W. Pisters R.A. Pollack Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy J Clin Oncol 17 1999 158-167
15. J.J. Nuyttens P.F. Rust C.R. Thomas Jr A.T. Turrisi III Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles Cancer 88 2000 1517-1523
16. N.B. Merchant J.J. Lewis J.M. Woodruff D.H. Leung M.F. Brennan Extremity and trunk desmoid tumors: A multifactorial analysis of outcome Cancer 86 1999 2045-2052
17. R.A. Zlotecki M.T. Scarborough C.G. Morris B.H. Berry D.S. Lind W.F. Enneking et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis Int J Radiat Oncol Biol Phys 54 2002 177-181
18. A. Gronchi P.G. Casali L. Mariani S. La Vullo M. Colecchia L. Lozza et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution J Clin Oncol 21 2003 1390-1397
19. M.T. Ballo G.K. Zagars A. Pollack Radiation therapy in the management of desmoid tumors Int J Radiat Oncol Biol Phys 42 1998 1007-1014